Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Mayo Clinic Laboratories and American Hospital Dubai announce a strategic partnership aimed at improving advanced laboratory diagnostics in the Dubai region. Under the agreement, the two organizations will begin delivering laboratory testing through a collaboration based out of American Hospital Dubai in early 2021.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the new COVID-19 variants that are emerging and how those variants could have an impact on the pandemic going forward.
Patrice Brown, PA(ASCP), shares her story of growing up in Virginia and moving to Rochester, Minnesota to work at Mayo Clinic. She also shares her unique perspective of traveling internationally as COVID-19 was starting to spread.
This week’s research roundup features a study on the IFCC clinical application of cardiac biomarkers committee's appraisal of the 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: getting cardiac troponin right.
The following list includes updates posted to mayocliniclabs.com during the month of December.
In this month’s “Hot Topic,” Gessi Pino, a genetic counselor in the Biochemical Genetics Lab at Mayo Clinic, and Kimiyo Raymond, M.D., a clinical consultant in the laboratory and an expert in Congenital Disorders of Glycosylation (CDG), discuss glycosylation and its importance in human biology, highlight laboratory testing, and offer strategies to screen and diagnose CDGs.
Top highlights include: recovering from COVID-19 at home using virtual technology, a weekly update from a Mayo Clinic infectious diseases expert, and the opioid crisis worsens during the pandemic.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., look back at how the COVID-19 pandemic reshaped laboratory medicine throughout 2020.
This week’s research roundup features a study on improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
Top highlights include: Mayo Clinic model of care and research leads to favorable outcomes for patients with COVID-19, addressing disparities to prevent disease, and new variant of the virus that causes COVID-19 detected.
Amir Sadighi Akha, M.D., D.Phil., lab section director for Mayo Clinic's Cellular and Molecular Immunology Laboratory, joins this episode of the "Answers From the Lab" podcast. Dr. Sadighi Akha and Bobbi Pritt, M.D., discuss dendritic cell enumeration — a new test offered through Mayo Clinic Laboratories that is the only clinical test of its kind currently available in the U.S.
This week’s research roundup features a study on systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer.